Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Enterobacteriaceae Infection Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Beta-lactams Drugs
1.2.3 Carbapenems Drugs
1.2.4 Fluoroquinolones Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Enterobacteriaceae Infection Drug Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Enterobacteriaceae Infection Drug Market Perspective (2018-2033)
2.2 Enterobacteriaceae Infection Drug Growth Trends by Region
2.2.1 Global Enterobacteriaceae Infection Drug Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Enterobacteriaceae Infection Drug Historic Market Size by Region (2018-2023)
2.2.3 Enterobacteriaceae Infection Drug Forecasted Market Size by Region (2024-2033)
2.3 Enterobacteriaceae Infection Drug Market Dynamics
2.3.1 Enterobacteriaceae Infection Drug Industry Trends
2.3.2 Enterobacteriaceae Infection Drug Market Drivers
2.3.3 Enterobacteriaceae Infection Drug Market Challenges
2.3.4 Enterobacteriaceae Infection Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Enterobacteriaceae Infection Drug Players by Revenue
3.1.1 Global Top Enterobacteriaceae Infection Drug Players by Revenue (2018-2023)
3.1.2 Global Enterobacteriaceae Infection Drug Revenue Market Share by Players (2018-2023)
3.2 Global Enterobacteriaceae Infection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Enterobacteriaceae Infection Drug Revenue
3.4 Global Enterobacteriaceae Infection Drug Market Concentration Ratio
3.4.1 Global Enterobacteriaceae Infection Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Enterobacteriaceae Infection Drug Revenue in 2022
3.5 Enterobacteriaceae Infection Drug Key Players Head office and Area Served
3.6 Key Players Enterobacteriaceae Infection Drug Product Solution and Service
3.7 Date of Enter into Enterobacteriaceae Infection Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Enterobacteriaceae Infection Drug Breakdown Data by Type
4.1 Global Enterobacteriaceae Infection Drug Historic Market Size by Type (2018-2023)
4.2 Global Enterobacteriaceae Infection Drug Forecasted Market Size by Type (2024-2033)
5 Enterobacteriaceae Infection Drug Breakdown Data by Application
5.1 Global Enterobacteriaceae Infection Drug Historic Market Size by Application (2018-2023)
5.2 Global Enterobacteriaceae Infection Drug Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Enterobacteriaceae Infection Drug Market Size (2018-2033)
6.2 North America Enterobacteriaceae Infection Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Enterobacteriaceae Infection Drug Market Size by Country (2018-2023)
6.4 North America Enterobacteriaceae Infection Drug Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Enterobacteriaceae Infection Drug Market Size (2018-2033)
7.2 Europe Enterobacteriaceae Infection Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Enterobacteriaceae Infection Drug Market Size by Country (2018-2023)
7.4 Europe Enterobacteriaceae Infection Drug Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size (2018-2033)
8.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Enterobacteriaceae Infection Drug Market Size (2018-2033)
9.2 Latin America Enterobacteriaceae Infection Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Enterobacteriaceae Infection Drug Market Size by Country (2018-2023)
9.4 Latin America Enterobacteriaceae Infection Drug Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size (2018-2033)
10.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genentech
11.1.1 Genentech Company Detail
11.1.2 Genentech Business Overview
11.1.3 Genentech Enterobacteriaceae Infection Drug Introduction
11.1.4 Genentech Revenue in Enterobacteriaceae Infection Drug Business (2018-2023)
11.1.5 Genentech Recent Development
11.2 Nanotherapeutics
11.2.1 Nanotherapeutics Company Detail
11.2.2 Nanotherapeutics Business Overview
11.2.3 Nanotherapeutics Enterobacteriaceae Infection Drug Introduction
11.2.4 Nanotherapeutics Revenue in Enterobacteriaceae Infection Drug Business (2018-2023)
11.2.5 Nanotherapeutics Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Enterobacteriaceae Infection Drug Introduction
11.3.4 Novartis Revenue in Enterobacteriaceae Infection Drug Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Enterobacteriaceae Infection Drug Introduction
11.4.4 Pfizer Revenue in Enterobacteriaceae Infection Drug Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 Nymox Pharmaceutical
11.5.1 Nymox Pharmaceutical Company Detail
11.5.2 Nymox Pharmaceutical Business Overview
11.5.3 Nymox Pharmaceutical Enterobacteriaceae Infection Drug Introduction
11.5.4 Nymox Pharmaceutical Revenue in Enterobacteriaceae Infection Drug Business (2018-2023)
11.5.5 Nymox Pharmaceutical Recent Development
11.6 Sequoia Sciences
11.6.1 Sequoia Sciences Company Detail
11.6.2 Sequoia Sciences Business Overview
11.6.3 Sequoia Sciences Enterobacteriaceae Infection Drug Introduction
11.6.4 Sequoia Sciences Revenue in Enterobacteriaceae Infection Drug Business (2018-2023)
11.6.5 Sequoia Sciences Recent Development
11.7 Phico Therapeutics
11.7.1 Phico Therapeutics Company Detail
11.7.2 Phico Therapeutics Business Overview
11.7.3 Phico Therapeutics Enterobacteriaceae Infection Drug Introduction
11.7.4 Phico Therapeutics Revenue in Enterobacteriaceae Infection Drug Business (2018-2023)
11.7.5 Phico Therapeutics Recent Development
11.8 Cantab Biopharmaceuticals
11.8.1 Cantab Biopharmaceuticals Company Detail
11.8.2 Cantab Biopharmaceuticals Business Overview
11.8.3 Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Introduction
11.8.4 Cantab Biopharmaceuticals Revenue in Enterobacteriaceae Infection Drug Business (2018-2023)
11.8.5 Cantab Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Enterobacteriaceae Infection Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Beta-lactams Drugs
Table 3. Key Players of Carbapenems Drugs
Table 4. Key Players of Fluoroquinolones Drugs
Table 5. Key Players of Others
Table 6. Global Enterobacteriaceae Infection Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Enterobacteriaceae Infection Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Enterobacteriaceae Infection Drug Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Enterobacteriaceae Infection Drug Market Share by Region (2018-2023)
Table 10. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Enterobacteriaceae Infection Drug Market Share by Region (2024-2033)
Table 12. Enterobacteriaceae Infection Drug Market Trends
Table 13. Enterobacteriaceae Infection Drug Market Drivers
Table 14. Enterobacteriaceae Infection Drug Market Challenges
Table 15. Enterobacteriaceae Infection Drug Market Restraints
Table 16. Global Enterobacteriaceae Infection Drug Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Enterobacteriaceae Infection Drug Market Share by Players (2018-2023)
Table 18. Global Top Enterobacteriaceae Infection Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterobacteriaceae Infection Drug as of 2022)
Table 19. Ranking of Global Top Enterobacteriaceae Infection Drug Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Enterobacteriaceae Infection Drug Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Enterobacteriaceae Infection Drug Product Solution and Service
Table 23. Date of Enter into Enterobacteriaceae Infection Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Enterobacteriaceae Infection Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2018-2023)
Table 27. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2024-2033)
Table 29. Global Enterobacteriaceae Infection Drug Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Enterobacteriaceae Infection Drug Revenue Market Share by Application (2018-2023)
Table 31. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Enterobacteriaceae Infection Drug Revenue Market Share by Application (2024-2033)
Table 33. North America Enterobacteriaceae Infection Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Enterobacteriaceae Infection Drug Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Enterobacteriaceae Infection Drug Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Enterobacteriaceae Infection Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Enterobacteriaceae Infection Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Enterobacteriaceae Infection Drug Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Enterobacteriaceae Infection Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Enterobacteriaceae Infection Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Enterobacteriaceae Infection Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Enterobacteriaceae Infection Drug Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Enterobacteriaceae Infection Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2024-2033) & (US$ Million)
Table 48. Genentech Company Detail
Table 49. Genentech Business Overview
Table 50. Genentech Enterobacteriaceae Infection Drug Product
Table 51. Genentech Revenue in Enterobacteriaceae Infection Drug Business (2018-2023) & (US$ Million)
Table 52. Genentech Recent Development
Table 53. Nanotherapeutics Company Detail
Table 54. Nanotherapeutics Business Overview
Table 55. Nanotherapeutics Enterobacteriaceae Infection Drug Product
Table 56. Nanotherapeutics Revenue in Enterobacteriaceae Infection Drug Business (2018-2023) & (US$ Million)
Table 57. Nanotherapeutics Recent Development
Table 58. Novartis Company Detail
Table 59. Novartis Business Overview
Table 60. Novartis Enterobacteriaceae Infection Drug Product
Table 61. Novartis Revenue in Enterobacteriaceae Infection Drug Business (2018-2023) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Pfizer Company Detail
Table 64. Pfizer Business Overview
Table 65. Pfizer Enterobacteriaceae Infection Drug Product
Table 66. Pfizer Revenue in Enterobacteriaceae Infection Drug Business (2018-2023) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Nymox Pharmaceutical Company Detail
Table 69. Nymox Pharmaceutical Business Overview
Table 70. Nymox Pharmaceutical Enterobacteriaceae Infection Drug Product
Table 71. Nymox Pharmaceutical Revenue in Enterobacteriaceae Infection Drug Business (2018-2023) & (US$ Million)
Table 72. Nymox Pharmaceutical Recent Development
Table 73. Sequoia Sciences Company Detail
Table 74. Sequoia Sciences Business Overview
Table 75. Sequoia Sciences Enterobacteriaceae Infection Drug Product
Table 76. Sequoia Sciences Revenue in Enterobacteriaceae Infection Drug Business (2018-2023) & (US$ Million)
Table 77. Sequoia Sciences Recent Development
Table 78. Phico Therapeutics Company Detail
Table 79. Phico Therapeutics Business Overview
Table 80. Phico Therapeutics Enterobacteriaceae Infection Drug Product
Table 81. Phico Therapeutics Revenue in Enterobacteriaceae Infection Drug Business (2018-2023) & (US$ Million)
Table 82. Phico Therapeutics Recent Development
Table 83. Cantab Biopharmaceuticals Company Detail
Table 84. Cantab Biopharmaceuticals Business Overview
Table 85. Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Product
Table 86. Cantab Biopharmaceuticals Revenue in Enterobacteriaceae Infection Drug Business (2018-2023) & (US$ Million)
Table 87. Cantab Biopharmaceuticals Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Enterobacteriaceae Infection Drug Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Enterobacteriaceae Infection Drug Market Share by Type: 2022 VS 2033
Figure 3. Beta-lactams Drugs Features
Figure 4. Carbapenems Drugs Features
Figure 5. Fluoroquinolones Drugs Features
Figure 6. Others Features
Figure 7. Global Enterobacteriaceae Infection Drug Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Enterobacteriaceae Infection Drug Market Share by Application: 2022 VS 2033
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Enterobacteriaceae Infection Drug Report Years Considered
Figure 13. Global Enterobacteriaceae Infection Drug Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Enterobacteriaceae Infection Drug Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Enterobacteriaceae Infection Drug Market Share by Region: 2022 VS 2033
Figure 16. Global Enterobacteriaceae Infection Drug Market Share by Players in 2022
Figure 17. Global Top Enterobacteriaceae Infection Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterobacteriaceae Infection Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Enterobacteriaceae Infection Drug Revenue in 2022
Figure 19. North America Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Enterobacteriaceae Infection Drug Market Share by Country (2018-2033)
Figure 21. United States Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Enterobacteriaceae Infection Drug Market Share by Country (2018-2033)
Figure 25. Germany Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Enterobacteriaceae Infection Drug Market Share by Region (2018-2033)
Figure 33. China Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Enterobacteriaceae Infection Drug Market Share by Country (2018-2033)
Figure 41. Mexico Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Enterobacteriaceae Infection Drug Market Share by Country (2018-2033)
Figure 45. Turkey Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Enterobacteriaceae Infection Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Genentech Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2018-2023)
Figure 48. Nanotherapeutics Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2018-2023)
Figure 51. Nymox Pharmaceutical Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2018-2023)
Figure 52. Sequoia Sciences Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2018-2023)
Figure 53. Phico Therapeutics Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2018-2023)
Figure 54. Cantab Biopharmaceuticals Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed